3.9 Article

Diabetes as a coronary artery disease risk equivalent: before a change of paradigm?

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1097/HJR.0b013e32833100f0

关键词

cardiovascular risk; coronary angiography; coronary artery disease; type 2 diabetes

资金

  1. Vorarlberger Industriellenvereinigung (Bregenz, Austria)
  2. Vorarlberger Aerztekammer (Dornbirn, Austria)
  3. Vorarlberger Landeskrankenhaus-Betriebsgesellschaft (Feldkirch, Austria)
  4. Liechtenstein Global Trust Bank (Bendern, Liechtenstein)
  5. Peter Goop Stiftung (Vaduz, Liechtenstein)
  6. Vorarlberger Landesregierung (Bregenz, Austria)
  7. Medizinisches Zentrallabor Feldkirch (Feldkirch, Austria)

向作者/读者索取更多资源

Background Current guidelines consider diabetes per se as a coronary artery disease (CAD) risk equivalent. We aimed at investigating the contribution of baseline coronary atherosclerosis to the risk of diabetic patients for future vascular events. Design Prospective cohort study. Methods Vascular events were recorded over 4 years in 750 consecutive patients undergoing coronary angiography for the evaluation of stable CAD. Results From our patients, 244 had neither type 2 diabetes (T2DM) nor significant CAD (i.e. coronary stenoses >= 50%) at the baseline angiography, 50 had T2DM but not significant CAD, 342 did not have T2DM but had significant CAD, and 114 had both T2DM and significant CAD. Nondiabetic patients without significant CAD had an event rate of 9.0%. The event rate was similar in T2DM patients without significant CAD (8.0%, P=0.951), but higher in nondiabetic patients with significant CAD (24.9%, P<0.001). Patients with T2DM and significant CAD had the highest event rate (43.0%). Importantly, T2DM patients without significant CAD had a significantly lower event rate than nondiabetic patients with significant CAD (P=0.008). Conclusion T2DM per se is not a CAD risk equivalent. Moderate-risk diabetic patients without significant CAD and very high-risk diabetic patients with significant CAD add up to a grand total of high-risk diabetic patients, this is why diabetes seems to be a CAD risk equivalent in many epidemiological studies. Eur J Cardiovasc Prev Rehabil 17:94-99 (C) 2010 The European Society of Cardiology

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据